Skip to main content

Clinical Management of Menopause-Related Sleep Disturbance

  • Chapter
  • First Online:
Essentials of Menopause Management

Abstract

Sleep disturbances are common during the menopause transition. Women with vasomotor symptoms may be more at risk for insomnia, particularly if night sweats cause awakenings. Other sleep difficulties, such as difficulty with initiating sleep, and early morning awakening can also occur often in this population. Psychiatric disorders, involving depressive and anxiety symptoms, and medical issues such as obstructive sleep apnea, restless legs syndrome, and incontinence are also common in this population and can contribute to sleep difficulties. Any sleep disturbance, regardless of cause, can lead to daytime fatigue and can negatively impact functioning and quality of life, and therefore, identifying and treating insomnia in menopausal women is essential for their well-being. With many options of pharmacological and non-pharmacological treatments for insomnia, tailoring treatment to a patient’s particular sleep issue and preference is ideal. This chapter focuses on the assessment and treatment of insomnia in menopausal women utilizing typical clinical case examples.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Keenan SA. Normal human sleep. Respir Care Clin N Am. 1999;5(3):319–31.

    CAS  PubMed  Google Scholar 

  2. Crowley SJ. Sleep behavior across the lifespan: How a model can expand our current understanding. Sleep Med Rev. 2015;S1087–0792(15):00162–8.

    Google Scholar 

  3. Woods NF, Mitchell ES. Sleep symptoms during the menopausal transition and early postmenopause: observations from the Seattle Midlife Women’s Health Study. Sleep. 2010;33(4):539–49.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Freeman EW, Sammel MD, Boorman DW, Zhang R. Longitudinal pattern of depressive symptoms around natural menopause. JAMA Psychiatry. 2014;71(1):36–43.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Yoon IY, Kripke DF, Elliott JA, et al. Age-related changes of circadian rhythms and sleep-wake cycles. J Am Geriatr Soc. 2003;51(8):1085–91.

    Article  PubMed  Google Scholar 

  6. American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-5. 5th ed. Arlington: American Psychiatric Association; 2013.

    Book  Google Scholar 

  7. Soules MR, Sherman S, Parrott E, Rebar R, Santoro N, Utian W, et al. Executive summary: Stages of Reproductive Aging Workshop (STRAW). Fertil Steril. 2001;76:874–8.

    Article  CAS  PubMed  Google Scholar 

  8. Freeman EW, Sammel MD, Liu L, Gracia CR, Nelson DB, Hollander L. Hormones and menopausal status as predictors of depression in women in transition to menopause. Arch Gen Psych. 2004;61:62–70.

    Article  CAS  Google Scholar 

  9. Epperson CN, Sammel M, Freeman EW. Menopause effects on verbal memory: Findings from a longitudinal community cohort. J Clin Endocrin Metab. 2013;98(9):3829–38.

    Article  CAS  Google Scholar 

  10. Shanmugan S, Epperson CN. Estrogen and the prefrontal cortex: towards a new understanding of estrogen’s effects on executive functions in the menopause transition. Hum Brain Mapp. 2014;35(3):847–65.

    Article  PubMed  Google Scholar 

  11. Dennerstein L, Dudley EC, Hopper JL, Guthrie JR, Burger HG. A prospective population-based study of menopausal symptoms. Obstet Gynecol. 2000;96(3):351.

    CAS  PubMed  Google Scholar 

  12. Kravitz HM, Ganz PA, Bromberger J, Powell LH, Sutton-Tyrrell K, Meyer PM. Sleep difficulty in women at midlife: a community survey of sleep and the menopausal transition. Menopause. 2003;10(1):19–28.

    PubMed  Google Scholar 

  13. Xu M, Belanger L, Ievers H, et al. Comparison of subjective and objective sleep quality in menopausal and non-menopausal women with insomnia. Sleep Med. 2011;12:65–9.

    Article  PubMed  Google Scholar 

  14. Young T, Finn L, Austin D, Peterson A. Menopausal status and sleep-disordered breathing in the Wisconsin Sleep Cohort Study. Am J Respir Crit Care Med. 2003;167:1181–5.

    Article  PubMed  Google Scholar 

  15. Owens JF, Matthews KA. Sleep disturbance in healthy middle-aged women. Maturitas. 1998;30(1):41–50.

    Article  CAS  PubMed  Google Scholar 

  16. Hollander LE, Freeman EW, Sammel MD, Berlin JA, Grisso JA, Battistini M. Sleep quality, estradiol levels, and behavioral factors in late reproductive age women. Obstet Gynecol. 2001;98(3):391–7.

    CAS  PubMed  Google Scholar 

  17. Kim TW, Jeong JH, Hong SC. The impact of sleep and circadian disturbance on hormones and metabolism. Int J Endocrinol. 2015;2015:591729.

    PubMed  PubMed Central  Google Scholar 

  18. Bolge SC, Balkrishnan R, Kannan H, Seal B, Drake CL. Burden associated with chronic sleep maintenance insomnia characterized by nighttime awakenings among women with menopausal symptoms. Menopause. 2010;17(1):80–6.

    Article  PubMed  Google Scholar 

  19. Shaver JL, Paulsen VM. Sleep, psychological distress, and somatic symptoms in perimenopausal women. Fam Pract Res J. 1993;13:373–84.

    CAS  PubMed  Google Scholar 

  20. Shaver J, Gblin E, Paulsen V. Sleep patterns and stability in perimenopausal women. Sleep. 1991;14:18–23.

    Article  CAS  PubMed  Google Scholar 

  21. Brown JP, Gallicchio L, Flaws JA, Tracy JK. Relations among menopausal symptoms, sleep disturbance and depressive symptoms in midlife. Maturitas. 2009;62(2):184–9.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Joffe H, Soares CN, Thurston RC, White DP, Cohen LS, Hall JE. Depression is associated with worse objectively and subjectively measured sleep, but not more frequent awakenings, in women with vasomotor symptoms. Menopause. 2009;16(4):671–9.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Kravitz H, Zhoa X, Bromberger J, et al. Sleep disturbance during the menopause transition in a multi-ethnic community sample of women. Sleep. 2008;31:979–90.

    PubMed  PubMed Central  Google Scholar 

  24. Paulsen V, Shaver JL. Stress, support, psychological states and sleep. Soc Sci Med. 1991;32:1237–43.

    Article  CAS  PubMed  Google Scholar 

  25. Freedman RR, Roehrs TA. Sleep disturbance in menopause. Menopause. 2007;14:1826–9.

    Article  Google Scholar 

  26. Freeman EW, Sammel MD, Lin H. Temporal associations of hot flashes and depression in the transition to menopause. Menopause. 2009;16(4):728–34.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Sowers MF, Zheng H, Kravitz HM, et al. Sex steroid hormone profiles are related to sleep measures from polysomnography and the Pittsburgh Quality Sleep INdex. Sleep. 2008;31:1339–49.

    PubMed  PubMed Central  Google Scholar 

  28. Gibson-Helm M, Teede H, Vincent A. Symptoms, health behavior and understanding of menopause therapy in women with premature menopause. Climacteric. 2014;17(6):666–73.

    Article  CAS  PubMed  Google Scholar 

  29. Lampio L, Polo-Kantola P, Polo O, et al. Sleep in midlife women: effects of menopause, vasomotor symptoms, and depressive symptoms. Menopause. 2014;21:1217–24.

    Article  PubMed  Google Scholar 

  30. Andersen ML, Bittencourt LRA, Antunes IB, Tufik S. Effects of progesterone on sleep: a possible pharmacological treatment for sleep-breathing disorders? Curr Med Chem. 2006;13(29):3575–82.

    Article  CAS  PubMed  Google Scholar 

  31. Gangwisch JE, Malaspina D, Boden-Albala B, Heymsfield SB. Inadequate sleep as a risk factor for obesity: analyses of the NHANES I. Sleep. 2005;28(10):1289–96.

    Article  PubMed  Google Scholar 

  32. Ikehara S, Iso H, Date C, et al. Association of sleep duration with mortality from cardiovascular disease and other causes for Japanese men and women: the JACC study. Sleep. 2009;32:259–301.

    Article  Google Scholar 

  33. Sabanayagam C, Shankar A. Sleep duration and cardiovascular disease: results from the National Health Interview Survey. Sleep. 2010;33:1037–42.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Cappuccio FP, D’Elia L, Strazzullo P, Miller MA. Sleep duration and all-cause mortality: a systematic review and meta-analysis of prospective studies. Sleep. 2010;33:585–92.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Vgontzas AN, Liao D, Pejovic S, et al. Insomnia with Short Sleep Duration and Mortality: The Penn State Cohort. Sleep. 2010;33(9):1159–64.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Mullington JM, Simpson NS, Meier-Ewert HK, Haack M. Sleep loss and inflammation. Best Pract Res Clin Endocrinol Metab. 2010;24(5):775–84.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Hachul de Campos H, Brandao LC, D’Almeida V, et al. Sleep disturbances, oxidative stress and cardiovascular risk parameters in postmenopausal women complaining of insomnia. Climacteric. 2006;9(4):312–9.

    Article  CAS  PubMed  Google Scholar 

  38. Anttalainen U, Saaresranta T, Aittokallio J, et al. Impact of menopause on the manifestation and severity of sleep-disordered breathing. Acta Obstet Gynecol Scand. 2006;85(11):1381–8.

    Article  PubMed  Google Scholar 

  39. Berger K, Luedemann J, Trenkwalder C, John U, Kessler C. Sex and the risk of restless legs syndrome in the general population. Arch Intern Med. 2004;164(2):196–202.

    Article  PubMed  Google Scholar 

  40. Allen R. Dopamine and iron in the pathophysiology of restless legs syndrome (RLS). Sleep Med. 2004;5(4):385–91.

    Article  PubMed  Google Scholar 

  41. Wesstrom J, Nilsson S, Sundstrom-Poromaa I, Ulfberg J. Restless legs syndrome among women: prevalence, co-morbidity and possible relationship to menopause. Climacteric. 2008;11(5):422–8.

    Article  CAS  PubMed  Google Scholar 

  42. Dzaja A, Wehrle R, Lancel M, Pollmächer T. Elevated estradiol plasma levels in women with restless legs during pregnancy. Sleep. 2009;32(2):169–74.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Jones HJ, Huang AJ, Subak LL, Brown JS, Lee KA. Bladder symptoms in early menopause. J Womens Health. 2017;25:457–63.

    Article  Google Scholar 

  44. Lukacz ES, Sampselle C, Gray M, Macdiarmid S, Rosenberg M, Ellsworth P, et al. A healthy bladder: a consensus. Int J Clin Pract. 2011;65(10):1026–36.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Altemus M, Sarvaiya N, Epperson CN. Sex differences in anxiety and depression: Clinical perspectives. Front Neuroendocrinol. 2014;35(3):320–30.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Seedat S, Scott KM, Angermeyer MC, Berglund P, Bromet EJ, Brugha TS, et al. Cross-national associations between gender and mental disorders in the World Health Organization World Mental Health Surveys. Arch Gen Psych. 2009;66(7):785–95.

    Article  Google Scholar 

  47. Schmidt PJ, Haq N, Rubinow DR. A longitudinal evaluation of the relationship between reproductive status and mood in perimenopausal women. Am J Psychiatry. 2004;161:2238–44.

    Article  PubMed  Google Scholar 

  48. Marsh WK, Templeton A, Ketter TA, Rasgon NL. Increased frequency of depressive episodes during the menopausal transition in women with bipolar disorder: preliminary report. J Psychiatr Res. 2008;42(3):247–51.

    Article  PubMed  Google Scholar 

  49. Altshuler LL, Kupka RW, Hellemann G, Frye MA, Sugar CA, McElroy SL, et al. Gender and depressive symptoms in 711 patients with bipolar disorder evaluated prospectively in Stanley Foundation bipolar treatment outcome network. Am J Psychiatry. 2010;167:708–15.

    Article  PubMed  Google Scholar 

  50. Benazzi F. The role of gender in depressive mixed state. Psychopathology. 2003;36:213–7.

    Article  PubMed  Google Scholar 

  51. Blehar MC, DePaulo Jr JR, Gershon ES, Reich T, Simpson SG, Nurnberger Jr JI. Women with bipolar disorder: findings from the NIMH Genetics Initiative sample. Psychopharmacol Bull. 1998;34(3):239–43.

    CAS  PubMed  Google Scholar 

  52. Seritan AL, Iosif AM, Park JH, et al. Self-reported anxiety, depressive, and vasomotor symptoms: a study of perimenopausal women presenting to a specialized midlife assessment center. Menopause. 2010;17(2):410–5.

    Article  PubMed  Google Scholar 

  53. Bromberger JT, Kravitz HM, Chang Y, Randolph Jr JF, Avis NE, Gold EB, et al. Self-reported anxiety, depressive, and vasomotor symptoms: a study of perimenopausal women presenting to a specialized midlife assessment center Study of women’s health across the nation. Menopause. 2010;20(5):488–95.

    Google Scholar 

  54. Siegel A, Mathews SB. Diagnosis and treatment of anxiety in the aging woman. Curr Psychiatry Rep. 2015;17:93.

    Article  PubMed  Google Scholar 

  55. Juang KD, Wang SJ, Lu SR, Lee SJ, Fuh JL. Hot flashes are associated with psychological symptoms of anxiety and depression in peri- and post- but not premenopausal women. Maturitas. 2005;52(2):119–26.

    Article  PubMed  Google Scholar 

  56. Freeman EW, Sammel MD, Lin H, Gracia CR, Kapoor S, Ferdousi T. The role of anxiety and hormonal changes in menopausal hot flashes. Menopause. 2005;12:258–66.

    Article  PubMed  Google Scholar 

  57. Tasdemir S, Oz O (2015). The factors causing bad sleep. Brain Behav Immun. pii: S0889-1591(15)30065-9. 53:278.

    Google Scholar 

  58. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1:385–401.

    Article  Google Scholar 

  59. Spielberger CD, Gorsuch RL, Lushene PR, Vagg PR, Jacobs AG. Manual for the State-Trait Anxiety Inventory (Form Y). Palo Alto: Consulting Psychologists Press, Inc.; 1983.

    Google Scholar 

  60. Johns M. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991;14(6):540–5.

    Article  CAS  PubMed  Google Scholar 

  61. Lichstein KL, Stone KC, Donaldson J, Nau SD, Soeffing JP, Murray D, et al. Actigraphy validation with insomnia. Sleep. 2006;29(2):232.

    PubMed  Google Scholar 

  62. Edinger JD, Wohlgemuth WK, Radtke RA, Marsh GR, Quillian RE. Cognitive behavioral therapy for treatment of chronic primary insomnia. JAMA. 2001;285(14):1856–64.

    Article  CAS  PubMed  Google Scholar 

  63. Mastin DF, Bryson J, Corwyn R. Assessment of sleep hygiene using the Sleep Hygiene Index. J Behav Med. 2006;29:223–7.

    Article  PubMed  Google Scholar 

  64. Green SM, Haber E, McCabe RE, Soares CN. Cognitive-behavioral group treatment for menopausal symptoms: a pilot study. Arch Womens Ment Health. 2013;16(4):325–32.

    Google Scholar 

  65. Keefer L, Blanchard EB. A behavioral group treatment program for menopausal hot flashes: results of a pilot study. Appl Psychophysiol Biofeedback. 2005;30(1):21–30.

    Article  PubMed  Google Scholar 

  66. Carmody JF, Crawford S, Salmoirago-Blotcher E, Leung K, Churchill L, Olendzki N. Mindfulness training for coping with hot flashes: results of a randomized trial. Menopause. 2011;18(6):611–20.

    Article  PubMed  PubMed Central  Google Scholar 

  67. Afonso RF, Hachul H, Kozasa EH, de Souza OD, Goto V, Rodrigues D, et al. Yoga decreases insomnia in postmenopausal women: a randomized clinical trial. Menopause. 2012;19(2):186.

    Article  PubMed  Google Scholar 

  68. Oliveira D, Hachul H, Tufik S, Bittencourt L. Effect of massage in postmenopausal women with insomnia: a pilot study. Clinics (Sao Paulo). 2011;66(2):343–6.

    Article  Google Scholar 

  69. Kung YY, Yang CC, Chiu JH, Kuo TB. The relationship of subjective sleep quality and cardiac autonomic nervous system in postmenopausal women with insomnia under auricular acupressure. Menopause. 2011;18(6):638–45.

    Article  PubMed  Google Scholar 

  70. Borud EK, Alraek T, White A, et al. The Acupuncture on Hot Flushes Among Menopausal Women (ACUFLASH) study, a randomized controlled trial. Menopause. 2009;16(3):484–93.

    Article  PubMed  Google Scholar 

  71. Passos GS, Poyares DL, Santana MG, Tufik S, Mello MT. Is exercise an alternative treatment for chronic insomnia? Clinics (Sao Paulo). 2012;67(6):653–60.

    Article  Google Scholar 

  72. Sternfeld B, Guthrie KA, Ensrud KE, LaCroix AZ, Larson JC, Dunn AL, et al. Efficacy of exercise for menopausal symptoms: a randomized controlled trial. Menopause. 2014;21(4):330–8.

    PubMed  PubMed Central  Google Scholar 

  73. NAMS. The 2012 hormone therapy position statement of: The North American Menopause Society. Menopause. 2012;19(3):257–71.

    Article  Google Scholar 

  74. Furness S, Roberts H, Marjoribanks J, Lethaby A. Hormone therapy in postmenopausal women and risk of endometrial hyperplasia. Cochrane Database Syst Rev. 2012;15:8.

    Google Scholar 

  75. Schiff I, Regestein Q, Tulchinsky D, Ryan KJ. Effects of estrogens on sleep and psychological state of hypogonadal women. JAMA: the journal of the American Medical Association. JAMA. 1979;242(22):2405–7.

    Article  CAS  PubMed  Google Scholar 

  76. Antonijevic IA, Stalla GK, Steiger A. Modulation of the sleep electroencephalogram by estrogen replacement in postmenopausal women. Am J Obstet Gynecol. 2000;182(2):277–82.

    Article  CAS  PubMed  Google Scholar 

  77. Saletu-Zyhlarz G, Anderer P, Gruber G, Mandl M, Gruber D, Metka M, Huber J, Oettel M, Gräser T, Abu-Bakr MH, Grätzhofer E, Saletu B. Insomnia related to postmenopausal syndrome and hormone replacement therapy: sleep laboratory studies on baseline differences between patients and controls and double-blind, placebo-controlled investigations on the effects of a novel estrogen-progestogen combination (Climodien, Lafamme) versus estrogen alone. J Sleep Res. 2003;12(3):239–54.

    Google Scholar 

  78. Welton AJ, Vickers MR, Kim J, et al. WISDOM team: Health related quality of life after combined hormone replacement therapy; randomized controlled trial. BMJ. 2008;337:1190.

    Article  Google Scholar 

  79. Kalleinen N, Polo O, Himanen SL, Joutsen A, Polo-Kantola P. The effect of estrogen plus progestin treatment on sleep: a randomized, placebo-controlled, double-blind trial in premenopausal and late postmenopausal women. Climacteric. 2008;11(3):233–43.

    Article  CAS  PubMed  Google Scholar 

  80. Montplaisir J, Lorrain J, Denesle R, Petit D. Sleep in menopause: differential effects of two forms of hormone replacement therapy. Menopause. 2001;8(1):10.

    Article  CAS  PubMed  Google Scholar 

  81. Purdie DW, Empson JA, Crichton C, Macdonald L. Hormone replacement therapy, sleep quality and psychological wellbeing. Br J Obstet Gynaecol. 1995;102(9):735–9.

    Article  CAS  PubMed  Google Scholar 

  82. Schussler P, Kluge M, Yassouridis A, et al. Progesterone reduces wakefulness in sleep EEG and has no effect on cognition in healthy postmenopausal women. Psychoneuroendocrinology. 2008;33(8):1124–31.

    Article  CAS  PubMed  Google Scholar 

  83. Gurney EP, Nachtigall MJ, Nachtigall LE, Naftolin F. The Women’s Health Initiative trial and related studies: 10 years later: A clinician’s view. J Steroid Biochem Mol Biol. 2014;142:4–11.

    Article  CAS  PubMed  Google Scholar 

  84. Lacey J. The WHI ten year’s later: An epidemiologist’s view. J Steroid Biochem Mol Biol. 2014;142:12–5.

    Article  CAS  PubMed  Google Scholar 

  85. Soares CN, Joffe H, Rubens R, Caron J, Roth T, Cohen L. Eszopiclone in patients with insomnia during perimenopause and early postmenopause: a randomized controlled trial. Obstet Gynecol. 2006;108(6):1402–10.

    Article  CAS  PubMed  Google Scholar 

  86. Joffe H, Petrillo L, Viguera A, et al. Eszopiclone improves insomnia and depressive and anxious symptoms in perimenopausal and postmenopausal women with hot flashes: a randomized, double-blinded, placebo-controlled crossover trial. Am J Obstet Gynecol. 2010;202(2):171.

    Article  PubMed  Google Scholar 

  87. Dorsey CM, Lee KA, Scharf MB. Effect of zolpidem on sleep in women with perimenopausal and postmenopausal insomnia: a 4-week, randomized, multicenter, double-blind, placebo-controlled study. Clin Ther. 2004;26(10):1578–86.

    Article  CAS  PubMed  Google Scholar 

  88. Dobkin RD, Menza M, Bienfait KL, Allen LA, Marin H, Gara MA. Ramelteon for the treatment of insomnia in menopausal women. Menopause Int. 2009;5(1):13–8.

    Google Scholar 

  89. Soares CN, Arsenio H, Joffe H, Bankier B, Cassano P, Petrillo LF, Cohen LS. Escitalopram versus ethinyl estradiol and norethindrone acetate for symptomatic peri- and postmenopausal women: impact on depression, vasomotor symptoms, sleep, and quality of life. Menopause. 2006;13(5):780–6.

    Article  PubMed  Google Scholar 

  90. Kornstein SG, Clayton AH, Bao W, Guico-Pabia CJ. A pooled analysis of the efficacy of desvenlafaxine for the treatment of major depressive disorder in perimenopausal and postmenopausal women. J Womens Health. 2015;24(4):281–90.

    Article  Google Scholar 

  91. Ensrud KE, Guthrie KA, Hohensee C, Caan B, Carpenter JS, Freeman EW, LaCroix AZ, et al. Effects of estradiol and venlafaxine on insomnia symptoms and sleep quality in women with hot flashes. Sleep. 2015;38(1):97–108.

    Article  PubMed  PubMed Central  Google Scholar 

  92. Ensrud KE, Joffe H, Guthrie KA, Larson JC, Reed SD, Newton KM, et al. Effect of escitalopram on insomnia symptoms and subjective sleep quality in healthy perimenopausal and postmenopausal women with hot flashes: a randomized controlled trial. Menopause. 2012;19(8):848–55.

    Article  PubMed  PubMed Central  Google Scholar 

  93. Waldinger MD. Psychiatric disorders and sexual dysfunction. Handb Clin Neurol. 2015;130:469–89.

    Article  PubMed  Google Scholar 

  94. Gilron I, Baron R, Jensen T. Neuropathic pain: principles of diagnosis and treatment. Mayo Clin Proc. 2015;90(4):532–45.

    Article  CAS  PubMed  Google Scholar 

  95. Johanessen Landmark C. (2015). Antiepileptic drugs in non-epilepsy disorders: relations between mechanisms of action and clinical efficacy. CNS Drugs. 2008;22(1):27–47.

    Article  Google Scholar 

  96. Howland RH. Gabapentin for the treatment of substance use disorders. J Psychosoc Nurs Ment Health Serv. 2013;51(12):11–4.

    Article  Google Scholar 

  97. Butt DA, Lock M, Lewis JE, Ross S, Moineddin R. Gabapentin for the treatment of menopausal hot flashes: a randomized controlled trial. Menopause. 2008;15:310–8.

    Article  PubMed  Google Scholar 

  98. Reddy SY, Warner H, Guttuso Jr T, et al. Gabapentin, estrogen and placebo for treating hot flashes: a randomized controlled trial. Obstet Gynecol. 2006;108:41–8.

    Article  CAS  PubMed  Google Scholar 

  99. Yurcheshen ME, Guttuso Jr T, McDermott M, Holloway RG, Perlis M. Effects of gabapentin on sleep in menopausal women with hot flashes as measured by a Pittsburgh Sleep Quality Index factor scoring model. J Womens Health (Larchmt). 2009;18:1355–60.

    Article  Google Scholar 

  100. Dolev Z. Case series of perimenopausal women with insomnia treated with mirtazapine followed by prolonged-release melatonin add-on and monotherapy. Arch Womens Health. 2011;14(3):269–73.

    Article  Google Scholar 

  101. Hasnain M, Vieweg WV. Weight considerations in psychotropic drug prescribing and switching. Postgrad Med. 2013;125(5):117–29.

    Article  PubMed  Google Scholar 

  102. Pansini F, Albertazzi P, Bonaccorsi G, Zanotti L, Porto S, Dossi L, et al. Trazodone: a non-hormonal alternative for neurovegetative climacteric symptoms. Clin Exp Obstet Gynecol. 1995;22(4):341–4.

    CAS  PubMed  Google Scholar 

  103. NAMS. Nonhormonal management of menopause-associated vasomotor symptoms: 2015 position statement of The North American Menopause Society. Menopause. 2015;22(11):1155–74.

    Article  Google Scholar 

Download references

Acknowledgments

The writing of this chapter was funded in part by the National Institutes of Health Office of Research on Women’s Health (P50 MH099910), the National Institute for Mental Health (P50 MH099910), the National Institute on Aging (R01 AG030641), the National Institute on Drug Abuse (R01 DA03289 and K24 DA030301), and the National Institute for Diabetes Digestive and Kidney Disorders (U01 DK106892).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to C. Neill Epperson MD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Mathews, S.B., Epperson, C.N. (2017). Clinical Management of Menopause-Related Sleep Disturbance. In: Pal, L., Sayegh, R. (eds) Essentials of Menopause Management. Springer, Cham. https://doi.org/10.1007/978-3-319-42451-4_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-42451-4_6

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-42449-1

  • Online ISBN: 978-3-319-42451-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics